Alphavirus vectors express high levels of recombinant proteins in mammalian cells, but their cytopathic nature makes this expression transient. In order to generate a Semliki Forest virus (SFV) noncytopathic vector we introduced mutations previously described to turn Sindbis virus noncytopathic into a conserved position in an SFV vector expressing LacZ. Interestingly, mutant P718T in replicase nsp2 subunit was able to replicate in only a small percentage of BHK cells, producing β-gal-expressing colonies without selection. Puromycin N-acetyltransferase (pac) gene was used to replace LacZ in this mutant allowing selection of an SFV noncytopathic replicon containing a second mutation in nsp2 nuclear localization signal (R649H). This latter mutation did not confer a noncytopathic phenotype by itself and did not alter nsp2 nuclear translocation. Replicase synthesis was diminished in the SFV double mutant, leading to genomic and subgenomic RNA levels that were 125-fold and 66-fold lower than in wild-type vector, respectively. Interestingly, this mutant expressed β-gal levels similar to parental vector. By coexpressing pac and LacZ from independent subgenomic promoters this vector was able to generate stable cell lines maintaining high expression levels during at least 10 passages, indicating that it could be used as a powerful system for protein production in mammalian cells.
Introduction
Alphavirus expression vectors have been developed from different viruses, which include Sindbis virus (SIN) (Xiong et al., 1989) , Semliki Forest virus (SFV) (Liljestrom and Garoff, 1991) and Venezuelan equine encephalitis virus (VEE) (Pushko et al., 1997) . Alphavirus vectors are usually based on RNA replicons in which the viral structural genes have been deleted and substituted by a heterologous gene. The alphavirus replicon contains an ORF coding for the viral replicase at its 5′ end, which is translated upon transfection of the RNA into eukaryotic cells. Replicase is expressed as a polyprotein which is sequentially processed into four subunits (nsps 1-4) (Strauss and Strauss, 1994; Vasiljeva et al., 2003) . Unprocessed replicase can copy the RNA vector into a negative strand RNA, a process which only takes place during the first 3-4 h of transfection/infection. Upon processing, the replicase will use the negative strand RNA as template to make more replicon molecules. Processed replicase can also recognize an internal sequence in the negative strand RNA, or subgenomic promoter, from which it will synthesize a subgenomic positive strand RNA corresponding to the 3′ end of the replicon, which contains the sequence of the heterologous gene. This subgenomic RNA will be translated to produce the heterologous protein at very high levels. The replicon RNA can also be packaged into viral particles by cotransfecting cells with one or more helper RNAs that are able to provide the viral structural proteins in trans (Berglund et al., 1993; Bredenbeek et al., 1993; Frolov et al., 1997; Pushko et al., 1997; Smerdou and Liljestrom, 1999) , or by using packaging cell lines (Polo et al., 1999) . The replication of alphavirus vectors is cytopathic in most mammalian cells, due to mechanisms which are not yet fully understood (Berglund et al., 1998; Frolov and Schlesinger, 1994a; Glasgow et al., 1997) . The cytopathic effect induced by these vectors is mediated by p53-independent apoptosis, and it usually takes place at 48-72 h posttransfection/infection (Glasgow et al., 1998) . It is suspected that nsp2, one of the 4 components of the viral replicase could play an important role in the induction of apoptosis (Frolova et al., 2002; Garmashova et al., 2006) . Alphavirus cytopathic vectors have been used for a number of applications including in vitro protein production and characterization (Wurm and Bernard, 1999) , as well as vaccination and cancer gene therapy studies (Lundstrom, 2003; Rayner et al., 2002) . However, one important drawback of the original vectors is the fact that they cannot be used in applications where long expression of the transgene is desired. In order to solve this problem several groups have identified a number of mutations in the alphavirus replicase that are able to render these vectors noncytopathic, allowing a more prolonged expression of the recombinant products expressed by the vector. These studies have led to the description of noncytopathic vectors derived from SIN Perri et al., 2000) , SFV (Lundstrom et al., , 2001 Perri et al., 2000) and more recently from VEE and EEE (Petrakova et al., 2005) . Most noncytopathic mutations detected in alphavirus have been mapped in the nsp2 subunit of the replicase. This protein contains an amino-terminal domain with nucleoside triphosphatase and helicase activities and a protease carboxy-terminal domain involved in the processing of replicase into its four subunits (Strauss and Strauss, 1994) . It has been shown that a number of noncytopathic mutations described for nsp2 affect either the proteolytic domain of nsp2, or positions close to cleavage sites between nsp1/2 and nsp2/3, altering in this way the processing of replicase. A well characterized noncytopathic mutant isolated from SIN that contained a single amino acid change (P to L) at position 726 in nsp2 showed a hyperprocessing of the replicase . This mutant was able to efficiently establish persistent replication in BHK cells. The introduction of different amino acid changes at the same position in this mutant showed that there was a strong positive correlation between the level of RNA replication and the cytopathogenicity of the vector. The SIN noncytopathic vector containing P726L mutation in nsp2 has been widely used in vitro, and although it was able to provide long transgene expression with a rather high stability, its expression level was only about 4% of that described for the parental SIN vector (Agapov et al., 1998) . In the case of the described SFV noncytopathic vectors a level of heterologous expression similar or higher than the one observed with the SFV parental vector has been reported (Lundstrom et al., 2001; Perri et al., 2000) . However, in many cases the stability of these vectors was low, leading to loss of expression within a few days .
The purpose of the present study was to develop new noncytopathic SFV vectors able to provide high expression levels of recombinant proteins. Since SFV and SIN share a high degree of sequence similarity in the nonstructural proteins we tested the possibility of generating new SFV noncytopathic mutants by introducing mutations described at the nsp2 726 position in SIN into the homologous sequence of SFV nsp2. To our surprise these mutations were not able to provide a noncytopathic phenotype by themselves but led to the appearance of noncytopathic SFV variants containing second adaptive mutations. We isolated in this way a new noncytopathic SFV vector containing mutations P718T and R649H in nsp2. This vector was characterized in detail, showing RNA levels in transfected cells that were 125-fold lower than those of the parental SFV vector. In spite of the low replication levels the new SFV double mutant was able to express heterologous proteins at levels similar to those of wt SFV vector.
Results

Construction and characterization of SFV vectors carrying noncytopathic mutations derived from SIN
We have evaluated the effect of noncytopathic mutations described in SIN in an expression vector derived from SFV. Two mutations affecting residue 726 in the nsp2 subunit of SIN replicase, P726T and P726F, which had been described as partially cytopathic and noncytopathic for SIN, respectively, were introduced into the homologous nsp2 residue in pSFV-1 plasmid, generating mutants pSFV-S2 and pSFV-S3, which carried mutations P718T or P718F in nsp2, respectively. In order to evaluate the cytopathogenicity of these new vectors reporter gene LacZ was cloned downstream of the viral subgenomic promoter, generating pSFV-S2-LacZ and pSFV-S3-LacZ, respectively. RNA was Fig. 1 . Evaluation of the cytopathogenicity of SFV vectors carrying mutations derived from SIN. SFV-LacZ plasmids containing mutations P718T (pSFV-S2-LacZ) and P718F (pSFV-S3-LacZ) in nsp2 were constructed as described in Materials and methods. RNA was transcribed in vitro from each of these plasmids as well as from parental pSFV3-LacZ and electroporated into BHK cells which where plated on 35-mm-diameter dishes at low confluence and stained with X-gal after being cultured for the indicated times. In the case SFV-S2-LacZ or SFV-S3-LacZ, transfected cells were passaged 1:5 after 96 h in culture. Very few positive cells where observed in SFV-S3-LacZ transfected dishes at 120 h posttransfection. A schematic representation of each vector RNA is shown above each set of pictures. Circle at the left end of vectors, cap; nsp, non structural proteins; horizontal arrow, SFV subgenomic promoter; An, poly A. synthesized in vitro from each of these plasmids and electroporated into BHK-21 cells which were cultured and analyzed for β-gal expression by X-gal staining at different times posttransfection (Fig. 1) . In contrast to cells electroporated with control SFV-LacZ RNA where at 24 h posttransfection more than 95% of the cells expressed β-gal and showed a cytopathic phenotype, only a small percentage (about 1%) of cells transfected with SFV-S2-LacZ or SFV-S3-LacZ RNAs expressed β-gal at early times posttransfection, not showing a cytopathic morphology. In the case of SFV-S2-LacZ the number of positive cells increased along time, being able to form large colonies of β-gal expressing cells at day 5 postelectroporation. This effect was much more attenuated in SFV-S3-LacZ, where no blue colonies were observed at day 5 after X-gal staining. These data suggested that mutations P718T and P718F might block viral replication or transgene expression, but give rise with a relative high frequency to noncytopathic variants that could be the result of second adaptive mutations appearing during in vitro transcription or SFV replication.
Selection and mapping of replicons derived from SFV-S2 containing new adaptive mutations
In order to select cell populations containing SFV noncytopathic replicons we substituted reporter gene LacZ in pSFV-S2-LacZ by the dominant selectable marker puromycin N-acetyl-transferase (pac) conferring puromycin resistance (de la Luna et al., 1988) , generating pSFV-S2-pac. Using this plasmid as template RNA was synthesized in vitro and electroporated into BHK-21 cells. At 24 h postelectroporation puromycin was added at 5 μg/ml, leading to the selection of drug resistant colonies, which were subsequently expanded. In order to identify putative adaptive mutations in the replicons present in selected cells total RNA was extracted from individual clones and a 3.9 kb fragment from the SFV replicase comprising whole nsp2 sequence was amplified by RT-PCR. We chose to amplify the nsp2 region of the replicase because most noncytopathic mutations described in alphaviruses have been mapped in this region. The cDNA fragment rescued from each clone was subcloned into parental pSFV-pac plasmid substituting the wild-type (wt) nsp2 sequence. In order to check if noncytopathic mutations had been rescued RNA was synthesized in vitro from each of the new plasmids and used to electroporate BHK-21 cells as described. 24 h after transfection puromycin was added at 5 μg/ ml and cells were stained with crystal violet at different times to compare their growth to that observed in cells transfected with the original SFV-S2-pac mutant or with parental SFV-pac. One of the clones, SFV-S2-9-pac, showed a clear noncytopathic phenotype since it conferred puromycin resistance to most transfected cells (Fig. 2) . Other clones that were tested showed a pattern similar to that of SFV-S2, suggesting that they could contain additional mutations in an area of the replicase different from nsp2, but they were not further analyzed for this study. Cells transfected with parental SFV-pac showed a clear cytopathic effect and most of them died before day 4. Sequencing of nsp2 fragment from pSFV-S2-9-pac showed that in addition to the original mutation P718T there was a second adaptive mutation in position 649 of nsp2 where Arg had been substituted by Hys. This new mutation affects the SFV nsp2 nuclear localization signal 648 RRR (Rikkonen, 1996) which in SFV-S2-9 changes to 648 RHR.
Effect of the R649H mutation on cytopathogenicity and on nsp2 nuclear localization In order to check the effect of mutation R649H by itself on the cytopathogenicity of SFV, this mutation was introduced into pSFV-pac as described in Materials and methods, generating plasmid pSFV-RHRpac. RNA was transcribed from this plasmid and electroporated into BHK-21 cells, which were left to recover for 24 h. At this time puromycin was added at 5 μg/ml and cell growth was analyzed at different times by staining the cells with crystal violet as described previously (Fig. 2 , SFV-RHR-pac column). SFV-RHR-pac showed a pattern very similar to that observed for parental vector SFV-pac, inducing an early strong cytopathic effect that led to death of most cells before day 4. These results suggested that lack of cytopathogenicity of vector SFV-S2-9 was due to the combination of mutations P718T and R649H. In order to check the effect of R649H mutation on nsp2 nuclear localization, cells were transfected with RNA from vectors containing this mutation (SFV-S2-9-pac and SFV-RHR-pac) or with vectors that did not have it (SFVpac and SFV-S2-pac) and analyzed by immunofluorescence with antibodies specific for the nuclear or the cytoplasmic form of SFV nsp2, respectively (Fig. 3A) . In all cases nsp2 was detected both in the nucleus and in the cytoplasm of transfected cells. In order to determine if the percentage of nsp2 translocated to the nucleus had been affected, cytoplasmic and nuclear fractions from the same cells were separated and analyzed by Western blot with a polyclonal antiserum specific for nsp2 (Fig. 3B) . The nsp2 cytoplasmic/nuclear ratio was very similar in cells transfected with any of the vectors suggesting that mutation R649H was not affecting nuclear trafficking of this protein.
RNA replication in SFV-S2-9-pac transfected cells
In order to determine the level of RNA replication of the double SFV noncytopathic mutant BHK cells were electroporated with SFV-S2-9-pac, total RNA was extracted at 24, 48, and 72 h postelectroporation, and analyzed by Northern blot with a 32 P-labeled oligonucleotide specific for the SFV subgenomic promoter sequence which is present in both genomic and subgenomic RNAs (Fig. 4, lanes 2-4) . The level of genomic and subgenomic SFV-S2-9-pac RNAs, as well as the ratio between them was compared to that obtained in cells transfected with parental SFVpac at 24 h postelectroporation (Fig. 4 , lane 5). SFV-S2-9-pac genomic and subgenomic RNAs increased with time seeming to reach a peak at 48 h postelectroporation (Fig. 4 , lanes 2-4). Similar RNA levels were observed in a BHK puromycin resistant cell line obtained with SFV-S2-9-pac (Fig. 4, lane 1) . In all cases SFV-S2-9 RNAs were produced at levels much lower than those obtained in cells transfected with the parental SFV-pac RNA (notice that lanes 1-4 in Fig. 4 were exposed 72 times longer than lane 5). Quantification of RNA levels with a phosphorimager resulted in 125-fold and 66-fold less genomic RNA and subgenomic RNA levels, respectively, in cells stably transfected with SFV-S2-9-pac as compared to cells transfected with SFV-pac. The subgenomic/genomic RNA ratio observed in SFV-S2-9-pac selected cells was about two-fold higher than that observed in cells transfected with SFV-pac (Fig. 4 , bottom numbers). However, in SFV-S2-9-pac nonselected cells this ratio was considerably higher, especially at 24 h after transfection, but diminished along time, indicating that synthesis of genomic RNA in the double mutant could be delayed with respect to that of subgenomic RNA. Two additional RNA bands with an intermediate size between genomic and subgenomic RNAs were also detected in cells transfected Mouse monoclonal antibodies specific for the nuclear (nsp2-n) or cytoplasmic (nsp2-c) forms of nsp2 were used as primary antibodies, and a polyclonal rabbit-antimouse IgG serum conjugated with FITC was used as a secondary antibody. Dapi-stained nuclei of the same cells were visualized with a UV filter (dapi). Images correspond to representative fields of one out of three experiments yielding a very similar result. B) Quantitative analysis of nsp2 in cytoplasmic (c) and nuclear fractions (n) of transfected cells. Samples were analyzed by Western blot by using a rabbit polyclonal antiserum specific for nsp2 (upper gel). As controls the same samples were analyzed with an antibody specific for a cytoplasmic protein (GAPDH, middle gel) or for a nuclear protein (lamin, lower gel). Numbers below the gels indicate the mean and standard deviation values for the ratio of cytoplasmic/nuclear nsp2 in each case, and correspond to three independent experiments.
with SFV-S2-9-pac (Fig. 4 , lanes 1-4). These bands were not further characterized but could correspond to defective interfering RNAs appearing during the replication of the double SFV mutant. Finally, in order to determine if the low levels of SFV-S2-9-pac RNA replication could be rescued by a wt replicase, BHK cells were simultaneously electroporated with SFV-S2-9-pac and parental SFV-LacZ RNAs. 24 h later total RNA was extracted from coelectroporated cells and analyzed by Northern blot as described (Fig. 4, lane 7) . RNA from cells electroporated with parental SFV-pac (Fig. 4 , lane 5) and SFV-LacZ (Fig. 4 , lane 6) were analyzed in the same gel and used as molecular size markers for each of the genomic and subgenomic RNAs. Both SFV-LacZ and SFV-S2-9-pac genomic and subgenomic RNAs were easily detected in coelectroporated cells after a short exposure of the gel, indicating that wt replicase was able to at least partially rescue replication of the double mutant. However, although the levels of both subgenomic RNAs were very similar, parental SFV-LacZ genomic RNA was produced at levels which in average were about 2-3 times higher than those of the SFV-S2-9-pac genomic RNA.
Replicase processing in the SFV-S2-9 mutant
The lower RNA levels detected in cells transfected with the SFV-S2-9-pac replicon could be due to an alteration in the processing of the replicase. SFV replicase is synthesized as polyprotein nsp1234 which is subsequently cleaved into its mature monomeric components by the protease activity present in the carboxy-terminal domain of nsp2 (Strauss and Strauss, 1994; Vasiljeva et al., 2003) , where both P718T and R649H mutations have been mapped. In order to examine the effect of these mutations on replicase processing, SFV-S2-9-pac and SFV-RHR-pac RNAs were translated in rabbit reticulocyte lysates in the presence of [ ]cysteine, and analyzed by SDS-PAGE on 8% gels followed by autoradiography. Two gels containing the same samples were run for different lengths of time in order to obtain a better separation of high molecular bands (upper gel, longer run), and to detect the lower molecular weight monomers nsp1, 3 and 4 (lower gel, shorter run). B) Analysis of replicase expression in transfected cells. Lysates from cells electroporated with the indicated mutant SFV-pac RNAs, parental SFV-pac (wt) or from control BHK cells (C), were analyzed by Western blot at different times postelectroporation by using a rabbit polyclonal antiserum specific for nsp2. The ratio of nsp2 expressed by SFV-pac/ nsp2 expressed by SFV-S2-9-pac or SFV-RHR-pac, respectively, at different time points is indicated below the gel. Numbers correspond to the mean and standard deviation of at least 2 independent experiments. The arrow indicates an unspecific band used as loading control. ⁎High molecular bands with size similar to nsp123 (upper band) and nsp12 (lower band). M, lane loaded with molecular weight markers (sizes indicated between gels). replicons and analyzed at 24 h (lanes 2, 5-7), 48 h (lane 3), or 72 h (lane 4) postelectroporation. The amount of genomic (g) and subgenomic (sg) SFV RNAs was analyzed by Northern blot with a 32 P-oligonuclotide specific for SFV subgenomic promoter as described in Materials and methods. The numbers at the bottom of the gels indicate the ratio of sg/g RNAs in each case. In lane 7 they refer to sg/g RNA ratio of SFV-S2-9-pac (pac) or SFV-LacZ (LacZ), respectively. A representative experiment is shown in which all samples were run on the same gel and transferred to nitrocellulose simultaneously. The left part of the gel (lanes 1-4) was exposed for 72 h while the right part (lanes 5-7) was exposed for 1 h.
parental SFV-pac by SDS-PAGE followed by autoradiography (Fig. 5A) . No differences were observed in the processing of the replicase between the two analyzed mutants and the wt replicase, resulting in a similar accumulation of nsp monomers in all cases. In order to determine if replicase processing was affected in vivo, BHK cells were electroporated with SFV-S2-9-pac, SFV-RHR-pac or SFV-pac RNAs and cell lysates were analyzed at different times posttransfection by Western blot with a rabbit antiserum specific for nsp2 (Fig. 5B) . The amount of nsp2 synthesized by the three analyzed vectors was very similar at 2 h posttransfection but increased considerably after 4 h in cells transfected with SFV-RHR-pac or SFV-pac, which correlated with the higher replication level of these two vectors. In addition to the nsp2 monomer two high molecular bands were detected in cells transfected with SFV-RHR-pac or SFV-pac RNA at 4 h posttransfection which could correspond to partially processed replicase (Fig. 5B) . These bands, which could correspond by size to intermediates nsp123 and nsp12, were almost undetectable in cells transfected with SFV-S2-9-pac RNA, suggesting a quicker processing of the replicase in this mutant. The lowest of these high molecular bands was also processed more slowly in cells transfected with SFV-RHR-pac as compared to SFV-pac (Fig. 5B, 24 h ), which could also be indicating that mutation RHR by itself can have a slight effect on replicase processing.
Packaging of SFV-S2-9 replicon
To facilitate this study reporter gene LacZ was cloned downstream of the SFV subgenomic promoter in pSFV-S2-9, generating plasmid pSFV-S2-9-LacZ. To determine the packaging efficiency of this vector BHK cells were coelectroporated with SFV-S2-9-LacZ and SFV helper-S and SFV helper C-S219A RNAs as described (Smerdou and Liljestrom, 1999) . Cell supernatants were collected at 24 h postelectroporation and titrated on BHK monolayers by X-gal staining (Table 1) . SFV-S2-9-LacZ RNA was packaged with a very low efficiency yielding titers of 7 × 10 3 vp/ml, which were much lower than those obtained with parental SFV-LacZ (5 × 10 9 vp/ml). In order to check if the presence of the wt replicase could increase the packaging efficiency of the double S2-9 mutant, BHK cells were coelectroporated with SFV-S2-9-LacZ, SFV-pac, and both SFV helper RNAs. In this case it was observed that parental SFV vector was able to moderately increase the production of SFV-S2-9-LacZ particles, which reached a titer of 1 × 10 5 vp/ml at 24 h postelectroporation, as determined by X-gal staining of BHK infected cells. Packaging of parental SFV-pac was only reduced about 5-fold in cells in which this vector was coelectroporated with SFV-S2-9-LacZ when compared to titers obtained when SFV-pac was packaged alone (determined by indirect immunofluorescence of infected cells using a rabbit polyclonal antiserum specific for SFV-nsp2 as primary antibody) (Table 1) . In order to determine the effect of each of the two individual mutations present in SFV-S2-9 in packaging, BHK cells were coelectroporated with both SFV helper RNAs and with either SFV-RHR-pac or SFV-S2-pac RNAs, and viral particles were titrated as described above for SFV-pac. SFV-RHR-pac was packaged at high titers (6.5 × 10 8 vp/ml) while SFV-S2-pac showed a very low efficiency of packaging (2 × 10 4 vp/ml).
Transgene expression in cells transfected with the SFV-S2-9 replicon
To determine the level of heterologous gene expression in the SFV double mutant RNA was synthesized in vitro from pSFV-S2-9-LacZ and used to electroporate BHK cells, in which β-gal expression was analyzed at different times postelectroporation. For comparison cells were also transfected with parental SFV-LacZ RNA, but were only analyzed at 24 h postelectroporation due to the cytopathic effect induced by this vector. A similar level of β-gal expression was observed in SFV-S2-9-LacZ and SFV-LacZ transfected cells at 24 h posttransfection, which was in the range of 15 pg/cell (Fig. 6 ). This expression level increased along time in cells transfected with SFV-S2-9-LacZ reaching a plateau of approximately 30 pg of β-gal/cell at 48 h posttransfection.
Production of a stable cell line expressing LacZ by using the SFV-S2-9 vector
As it has been shown in this study the SFV-S2-9-pac vector can be used to select cells that are able to maintain the replicon in the Fig. 7 . Stability of β-gal expression in cells transfected with SFV-S2-9-LacZ-pac. BHK cells were electroporated with SFV-S2-9-LacZ-pac RNA and selected in the presence of puromycin at 5 μg/ml. Selected cells were passaged every 2-3 days with or without puromycin and the percentage of β-gal positive cells was determined at each passage by X-gal staining. The data correspond to the mean of three independent experiments, with the standard deviation shown. The picture within the graph shows a typical field of BHK cells containing SFV-S2-9-LacZ-pac passaged 9 times in the presence of puromycin and stained with X-gal.
presence of puromycin. In order to study if it was possible to use this type of vector to generate stable cell lines expressing other transgenes reporter gene LacZ was introduced into pSFV-S2-9-pac, generating plasmid pSFV-S2-9-LacZ-pac, in which pac and LacZ genes are placed downstream of independent subgenomic promoters. RNA was synthesized in vitro from this plasmid and electroporated into BHK cells. At 24 h postelectroporation puromycin was added at 5 μg/ml and when selected cells reached confluency they were passaged ten times in the presence of the antibiotic during a period of 28 days. The percentage of β-gal-expressing cells, determined in each passage by X-gal staining, varied between 70% and 90%, but was 85% at passage 10, indicating a very high stability of transgene expression in the presence of selection (Fig. 7) . When selected cells were passaged without puromycin the percentage of β-gal-expressing cells diminished very quickly, being below 5% after 3 passages. The level of β-gal expression in cells selected with puromycin was determined after 6 and 8 passages (corresponding to 18 and 24 days in culture, respectively), reaching 13 and 18 pg/cell, respectively. These values are very similar to those obtained in cells transfected with parental vector SFV-LacZ at 24 h posttransfection, indicating that cell lines generated with the SFV-S2-9 vector could be used to express recombinant proteins at high levels.
Discussion
Most noncytopathic alphavirus mutants that have been described carry mutations in nsp2. However, in spite of a high percentage of sequence similarity between different alphaviruses, these mutations affected different residues in different viruses. Taking advantage of this sequence homology we investigated the effect of a well characterized SIN noncytopathic mutation affecting residue 726 of nsp2 in the context of SFV. Mutations P726L and P726T had been described as noncytopathic by Frolov et al. (1999) and by Perri et al. (2000) , respectively. In the first study residue 726 was also mutagenized to all other possible residues, generating a collection of SIN mutants with different degrees of cytopathogenicity. Frolov et al. (1999) were able to establish a correlation between the level of RNA replication and the cytopathogenicity, concluding that those changes in nsp2 726 that reduced RNA levels to less than 5% of the wt vector produced a noncytopathic phenotype. We chose two different changes, P726T and P726F which were able to reduce RNA levels in SIN to 5.1% and 1.6%, respectively, and introduced the corresponding mutations in the equivalent position 718 of SFV nsp2 (S2 and S3 mutants respectively). None of these changes was able to produce a noncytopathic phenotype in SFV by itself. Studies performed by transfecting cells with these mutants carrying reporter gene LacZ showed that only a small percentage of transfected cells were able to sustain the replication of the vector. The S2 mutant (P718T) seemed to be more stable than S3 (P718F) giving rise to large colonies of positive cells in the absence of selection. We hypothesized that these colonies contained replicons with additional adaptive mutations. In order to select these colonies and identify the putative second mutations present in the replicons we cloned the N-acetyl-transferase (pac) gene into the SFV S2 mutant and isolated cell colonies grown in the presence of puromycin. In one of the analyzed clones we found a second mutation at position 649 of nsp2 (R649H), which in combination with P718T was able to provide a noncytopathic phenotype to the SFV vector. Mutation R649H affects the 648 RRR nuclear localization signal of SFV which has been described as being responsible for partial transport of nsp2 to the cell nucleus (Rikkonen, 1996) . The change of Arg by Hys at position 649 constitutes a very conservative change, which could explain the fact that no apparent effect on nsp2 nuclear transport was observed either in the double S2-9 mutant or in the single R649H mutant. The latter mutant did not show any reduction in cytopathogenicity as compared to the parental SFV vector, indicating that both mutations at positions 649 and 718
were required to suppress the cytopathic effect. A more drastic change at the 649 position (R649D) had been previously described by Fazakerley et al., (2002) leading to the attenuation of the neurovirulence of SFV in the context of a full viral genome. In that case mutation R649D completely disrupted nsp2 transport to the nucleus, although it did not abolish the cytopathic effect of the virus on BHK cells. All together these data suggest that the 648 RRR sequence of nsp2 could be involved in the cytopathogenicity of SFV, although more detailed mutagenesis studies will be required to determine the precise role of this sequence on the induction of cell death.
The S2-9 mutant was able to replicate at levels which were about 125 times lower than those observed for the wt SFV vector, which could explain the lack of cytopathogenicity of this vector. The level of subgenomic RNA in S2-9 was only 66 times lower than that of the wt SFV vector, indicating that the ratio of subgenomic/genomic RNA was increased about two-fold in the noncytopathic mutant. Both the decrease in RNA levels and the increase in the subgenomic/genomic RNA ratio observed for S2-9 were very similar to those described in SIN vectors containing noncytopathic mutations in position 726 of nsp2 Perri et al., 2000; Sawicki et al., 2006) . However, these results are in contrast with those described by Perri et al. (2000) for SFV noncytopathic mutants where RNA levels where higher than those of wt virus, and in which also subgenomic/genomic RNA ratios were decreased, suggesting that different mechanisms could be involved in the establishment of persistent replication in the SFV mutants isolated by this group. The lower level of RNA replication in S2-9 was not due to a cis effect of mutations present in the RNA sequence, as it was shown by the fact that a wt replicase provided from a parental SFV vector could rescue the S2-9 genomic and subgenomic RNA levels to values close to those of wt SFV vector.
Synthesis of replicase was diminished in cells transfected with S2-9 after 4 h posttransfection which can contribute to the lower replication level of this mutant. The lower replicase expression at 24 h posttransfection is in contrast with the high level of heterologous protein expression observed in cells transfected with SFV-S2-9-LacZ, but could be due to the higher subgenomic/genomic RNA ratio present in S2-9 mutant. At 24 h posttransfection this ratio is about 4-fold higher in S2-9 with respect to wt (Fig. 4) , indicating that the amount of available S2-9 genomic RNA that can be translated to produce the replicase is very limited. Since the amount of S2-9 genomic RNA increases after 24 h posttransfection the amount of expressed replicase will probably be higher at later times. In fact the amount of nsp2 in a stable cell line containing a SFV-S2-9-pac replicon is only 1.5-fold lower than in wt transfected cells (data not shown). Several studies with alphavirus have shown that mutations in the C-terminal protease domain of nsp2 alter the processing of the replicase (Balistreri et al., 2007) and noncytopathic mutations in this domain led to either a hyperprocessing of the replicase or to a slower processing of this polyprotein (Perri et al., 2000) . In our case Western blot analysis of transfected cells suggested that a hyperprocessing of the replicase could be taking place in vivo for mutant S2-9. This quicker processing would result in low levels of intermediate nsp123 which is responsible for minus strand RNA synthesis during the first hours after transfection. Overall, low minus RNA synthesis would lead to lower genomic and subgenomic RNA levels, as it was observed by Northern blot. The fact that we were not able to detect differences in replicase processing between the S2-9 mutant and the wt vector by in vitro translation (even when the reaction time was reduced to 15 min, data not shown) could indicate that this process could be affected by cellular factors not present in vitro. In the case of mutant RHR a slight effect on the processing of the replicase was also observed in vivo at 24 h posttransfection, although this did not lead to differences in nsp2 expression or cytopathogenicity.
The packaging efficiency of the S2-9 mutant was about 6 log lower than that of a wt SFV vector carrying the same transgene. This could be due either to low RNA replication levels (including helper RNAs), or to a packaging deficiency of the double SFV mutant. Packaging experiments in which the S2-9 mutant was replicated at almost normal levels by cotransfection of cells with a wt SFV vector were able to increase the titer of S2-9 viral particles only about 15-fold, indicating that the low RNA levels were only partially responsible for the low packaging efficiency of this vector. The fact that wt SFV was simultaneously packaged at normal titers in these cells indicates that the low packaging efficiency of S2-9 was not due to low replication of helper RNAs. The SFV vector containing only the R649H mutation was packaged at wt levels, while the SFV vector containing only mutation P718T (SFV-S2) was packaged very poorly. Although the fact that vector SFV-S2 was not able to replicate in most transfected cells could be responsible for this low packaging efficiency, it seemed that this mutation alone or in combination with R649H was affecting the encapsidation of SFV RNA into viral particles. The SFV packaging signals have been mapped in a region of the genome comprising nucleotides 2767-2824 (White et al., 1998) , which does not overlap with any of the mutations present in S2-9, located at positions 3643 (R649H) and 3849-51 (P718T). However, it cannot be discarded that these mutations could affect the secondary structure of genomic RNA, altering the accessibility of the packaging signals. More mutagenesis studies will be required to determine the precise role of these new sequences in the packaging of SFV.
In spite of the low replication levels of the S2-9 mutant the amount of β-galactosidase produced by SFV-S2-9-LacZ at 24 h posttransfection was very similar to that obtained from a wt SFV vector expressing the same transgene. The expression level of S2-9 increased about two-fold at later times posttransfection, correlating with the observed increase in RNA levels. The level of recombinant protein expression in other described noncytopathic vectors has shown a great variability, ranging from only 4% of the wt expression in the case of SIN P726L mutant (Agapov et al., 1998) to 1000% in the case of the SFV-PD double mutant developed by Lundstrom et al. (2001) . However, in the latter case the expression levels provided by this vector dropped drastically after 3 days postinfection, probably due to a certain degree of cytopathogenicity in that vector . Some additional mutants described by this group containing temperature sensitive mutations were also able to express high levels of recombinant proteins, but only at the permissive temperature (Lundstrom et al., , 2001 . The reason why the S2-9 mutant could express higher levels of recombinant protein than the wt vector having much lower RNA levels could be related to the strong inhibition of protein synthesis induced by this latter vector. Two relatively recent publications point out to the phosphorylation of eIF2alpha as the mechanism by which alphavirus induce host cell protein shut-off at late times during infection (McInerney et al., 2005; Ventoso et al., 2006) . At the same time these authors showed that the translation enhancer element present in the 5′ end of the capsid gene allows efficient translation of the viral structural polyprotein in the presence of phosphorylated eIF2alpha. When fused in frame with the amino-terminal end of a recombinant protein in the SFV or SIN vector the capsid enhancer has shown to increase the level of expression of the recombinant protein about 8-fold (Frolov and Schlesinger, 1994b; Sjoberg et al., 1994; Smerdou and Liljestrom, 1999) . This effect was not observed in the context of the S2-9 vector (data not shown), most likely because no inhibition of translation by eIF2alpha phosphorylation was taking place in cells transfected with the noncytopathic vector. The absence of protein synthesis inhibition in cells transfected with the S2-9 vector could result in high expression levels with RNA levels much lower than those reached with the wt SFV vector. A similar observation has been reported by Gorchakov et al. (2004) with a partially noncytopathic SIN P726G mutant vector expressing GFP.
Finally we have shown that SFV-S2-9 vector can be efficiently used to generate BHK stable cell lines expressing recombinant proteins. For that purpose the vector contained the desired transgene and the pac gene under independent subgenomic promoters and cells were grown in the presence of puromycin. By using LacZ as reporter transgene we generated cell lines that showed very high stability, with 85% of cells expressing β-gal after 10 passages in culture, and with maintained expression levels that were similar to those of the wt SFV vector. This is contrast to what it was observed for a similar β-gal-expressing cell line generated with a noncytopathic SIN vector carrying mutation P726L in nsp2, which expressed β-gal at levels about 25-fold lower than wt SIN (Agapov et al.,1998) . In this latter case expression of LacZ was lost in 50% of cells after 3-4 passages, although a higher stability could be reached if the cell line was derived from a cloned population of β-gal positive cells. Clone selection seemed not to be necessary to obtain highly stable cell lines with the SFV-S2-9-LacZ-pac vector, which allowed quick selection of a high number of β-gal-expressing cells upon transfection.
As it has been shown for other alphavirus noncytopathic mutants (Agapov et al., 1998 ) the SFV-S2-9 double mutant worked only in BHK cells, and partially in CHO and Vero cells, (data not shown) probably due to type I-IFN response defects in these cell lines, that allow them to sustain RNA replication (Frolova et al., 2002) .
In summary, we have developed and characterized a new SFV noncytopathic vector which is able to express high levels of foreign proteins in transfected cells. The SFV-S2-9-pac vector could represent a novel alternative method for rapid generation of stable mammalian cell lines able to produce recombinant proteins at high levels. These cell lines could also be very useful to perform protein functional studies under conditions in which the viability of the cells is not compromised.
Materials and methods
Plasmid constructs
Plasmids pSFV-1 and pSFV3-LacZ have been previously described and were kindly provided by Dr. P. Liljeström (Karolinska Institute, Stockholm) (Liljestrom and Garoff, 1991) . In order to construct plasmids pSFV-S2 and pSFV-S3, a fragment of 3.5 kb containing the area of nsp2 to be mutated was extracted from pSFV-1 with SacI/XhoI and subcloned into pBluescript SK digested with the same enzymes, generating plasmid Blu-nsp2. Mutations P718T and P718F in nsp2 were introduced into this plasmid by crossover PCR. Outside primers SF3669-VS (5′-AATGTCACAGGCGCCGATAGG-3′) and SF4096-RS (5′-GGTGCACACCCGGCCGTGTGC-3′) were combined in sequence with pairs of oligonucleotides designed to introduce the respective mutations. For S2, the pair of internal oligos used was mutS2-VS (5′-GACTGCTAAAAACGGGCGGCAGCCTCTTGATGAGAGC-3′) and mutS2-RS (5′-AAGAGGCTGCCGCCCGTTTTTAGCAGTCGTAGCGCATC-3′) which overlap 25 nucleotides and in which codon CCC coding for Pro 718 in nsp2 has been mutated to ACG coding for Thr (underlined). For S3 the internal oligos used were mutS3-VS (5′-GACTGCTAAAATTTGGCGG-CAGCCTCTTGATGAGAGC-3′) and mutS3-RS (5′-AAGAGGCTGCCGC-CAAATTTTAGCAGTCGTAGCGCATC-3′) which overlap 25 nucleotides and in which CCC codon coding for nsp2 Pro 718 has been mutated to TTT coding for Phe (underlined). Crossover PCR was performed with Pfu and yielded DNA fragments of 430 bp which were digested with EagI/NarI and cloned into Blu-nsp2 after partial digestion with EagI and total digestion with NarI, generating Blu-nsp2-S2 or Blu-nsp2-S3, respectively. The presence of S2 or S3 mutations in these plasmids was confirmed by sequencing. Finally, a 3.5 kb SacI/XhoI fragment containing mutated nsp2 was extracted from Blu-nsp2-S2 or Blunsp2-S3 and subcloned into pSFV-1 digested with the same enzymes, generating plasmids pSFV-S2 and pSFV-S3, respectively. In order to clone LacZ into these plasmids a DNA fragment of 3.86 kb containing this gene was extracted with XbaI/XmaI from pSFV3-LacZ and cloned into pSFV-S2 or pSFV-S3 digested with the same enzymes, generating plasmids pSFV-S2-LacZ and pSFV-S3-LacZ, respectively.
In order to generate plasmid pSFV-pac a DNA fragment of 0.95 kb containing puromycin N-acetyl-transferase gene (pac) was extracted from plasmid pBSpac (de la Luna et al., 1988) (kindly provided by Dr. J. Ortin, CNB, Madrid, Spain) by digestion with NotI and HpaI. Upon blunting the NotI end with Klenow this fragment was cloned into pSFV-1 digested with SmaI, generating pSFV-pac. pSFV-S2-pac was generated by substituting the 3.5 kb SacI/XhoI fragment containing most of nsp2 in pSFV-pac by the same fragment obtained from Blunsp2-S2, containing mutation S2.
Plasmid pSFV-S2-9-LacZ was generated by substituting the 3.2 kb RsrII/XhoI fragment in pSFV3-LacZ by the same fragment obtained from pSFV-S2-9-pac which covers the area of the replicase containing both P718T and R649H nsp2 mutations. In order to generate pSFV-S2-9-LacZ-pac a DNA cassette of 1.9 kb containing SFV subgenomic promoter followed by pac gene was extracted from pSFV-pac with MscI/SpeI, and cloned into pSFV-S2-9-LacZ digested with SmaI/SpeI.
To generate pSFV-RHR-pac, mutation R649H in nsp2 was first introduced into Blu-nsp2 by PCR. Briefly, a PCR fragment of 1.67 kb was obtained with oligos SF1947-VS (5′-CGGTCCCTGAGTTTCAAG-3′) and SF3623-S29-RS (5′-AGCACCTATCGGCGCCTGTGACATTCAGCGGT-GACAACCAAGTGACCCTGTGTCGAGGCAAAGCCAGGTTG-3′) with Pfu using pSFV-1 as template. In the latter oligo, codon CGC has been substituted by CAC leading to mutation R649H in nsp2 (underlined, notice that the primer contains the reverse sequence). The sequence of this oligo spans the nearby NarI site present in the nsp2 gene (in italics). The PCR fragment was digested with BstEII/NarI, resulting in a 1.36 kb DNA fragment that was cloned into Blu-nsp2 digested with the same enzymes, generating in this way Blu-nsp2-RHR. Finally, a 3.5 kb SacI/XhoI fragment containing mutated nsp2 was extracted from Blunsp2-RHR and subcloned into pSFV-pac digested with the same enzymes, generating plasmid pSFV-RHR-pac.
RNA transcription and transfection
Purified plasmid DNAs were linearized by digestion with SpeI and transcribed in the presence of cap analog (New England Biolabs, USA) by using SP6 polymerase (Amersham-Pharmacia, USA-Sweden) as described (Liljestrom and Garoff, 1994) . In vitro synthesized RNAs were transfected into BHK-21 cells by electroporation as described previously (Liljestrom and Garoff, 1994) . In all cases 50 μg of each RNA were used to transfect 10 7 BHK cells.
Packaging of replicons
Packaging of recombinant RNA into SFV viral particles was performed by coelectroporation of BHK-21 cells with the recombinant RNA and both helper-S2 and helper-C-S219A SFV RNAs as described (Smerdou and Liljestrom, 1999) . SFV particles carrying LacZ as reporter gene were titrated by X-gal staining of BHK cells infected with serial dilutions of the virus. For SFV particles carrying pac gene indirect immunofluorescence of infected BHK-21 cells was performed by using a rabbit polyclonal antiserum specific for SFV nsp2 as primary antibody (E. Casales, unpublished results).
Selection and passaging of puromycin-resistant cell lines
Puromycin stocks (1 mg/ml) (Sigma, St. Louis, USA) were prepared in MEM, filtered and stored at −20°C. After transfection of BHK cells with recombinant SFV RNAs carrying the pac gene cells were allowed to recover for 24 h before addition of puromycin at 5 μg/ml. To select for puromycin resistant cells medium was replaced every 2-3 days with fresh puromycin containing medium. Upon selection, cells were always passaged in the presence of puromycin at the indicated concentration. In the case of cells transfected with SFV-S2-pac, individual foci were cloned, expanded and stored frozen in liquid nitrogen.
Mapping of adaptive mutations
Total cellular RNA from puromycin-resistant cells obtained after transfection with SFV-S2-pac RNA was isolated by using RNeasy kit (Qiagen, Germany). 5 μg of RNA from each clone were used to synthesize a cDNA with M-MLV reverse transcriptase (Promega, Madison, USA) by using a negative sense oligonucleotide complementary to SFV nucleotides 4977-5010 (5′-TCTCGCACTTTACCTTCTG-CACCCCATCTACATG-3′) as primer. After reverse transcription cDNAs were amplified by 30 cycles of PCR with Taq Plus Long (Stratagene, La Jolla, USA), the same negative sense primer and a positive-sense oligonucleotide complementary to SFV nucleotides 1040-1074 (5′-CACAGACACTGTCAAAGGAGAAAGAGTCTCATTCC-3′). The resulting 3971-bp fragment was digested with BclI (1106) and Bsu36I (4916) and cloned into the corresponding sites of pSFV-pac. Plasmid DNA derived from each individual clone was linearized and used as template to synthesize RNA in vitro, which was subsequently transfected into BHK cells to determine its ability to confer puromycin resistance. When the subregion comprised between positions 1106-4916 was able to allow cell survival and division in the presence of puromycin, as it was the case with clone S2-9, it was completely sequenced from two independent plasmid clones.
RNA analysis
Total RNA was extracted from transfected cells or from selected cell lines by using RNeasy minikit (Qiagen, Germany) and analyzed by Northern blot. 3 μg of total RNA were size fractionated on a 1.2% agarose/formaldehyde gel, transferred to a nitrocellulose membrane (Hybond-N+, Amersham, USA), and hybridized to a 32 P-labeled oligonucleotide specific for SFV subgenomic promoter (5′-GAATTC-TGTGTATTAACGCAC-3′). Relative amounts of SFV genomic and subgenomic RNAs were determined by using a phosphorimager (Cyclone, Packard, USA) and Optiquant software (version 4.0, Packard).
Analysis of replicase expression and processing
For cell-free translation experiments SFV RNAs were first transcribed in vitro as described earlier, purified with RNeasy kit (Qiagen, Germany), mixed with nuclease-treated rabbit reticulocyte lysates (Promega, USA) in the presence of a mixture of [ according to the manufacturer's instructions. Each translation reaction contained 2.3 μg of purified transcript RNA. Translation reactions were terminated by the addition of Laemmli sample buffer and analyzed by SDS-PAGE in 8% polyacylamide gels followed by autoradiography. For Western blot experiments whole cell lysates from SFV transfected BHK cells were obtained by incubation in a buffer containing 1% Igepal (Sigma, St. Louis, USA), 50 mM Tris-HCl pH 7.6, 150 mM NaCl, 2 mM EDTA and 1 μg/ml PMSF (Sigma, St. Louis, USA), cleared by centrifugation for 6 min at 6000 rpm in a refrigerated microcentrifuge and quantified by Bradford assay. Lysates were analyzed by SDS-PAGE in 8% polyacylamide gels, transferred to a nitrocellulose membrane and incubated with a rabbit polyclonal antisera specific for SFV nsp2 (E. Casales, unpublished results). An HRP-conjugated sheep-antirabbit antiserum was used as secondary antibody. Proteins were visualized using the Western Lightning Chemiluminiscence Reagent Plus (Perkin Elmer Life Sciences, USA), scanned with an ImageQuant ECL imager (GE Healthcare, Chalfont St. Giles, UK) and quantitated with ImageQuant TL software (GE Healthcare, Chalfont St. Giles, UK). For nuclear localization studies cytoplasmic and nuclear fractions of transfected cells were separated previous to Western blot by resuspending cells in a buffer containing 0.5% Igepal, 10 mM Tris-HCl pH 8.5, 150 mM NaCl, 1.5 mM Cl 2 Mg and performing 3 cycles of 3-mincentrifugation at 2000 rpm to pellet cell nuclei. As control of fraction purity all samples were also analyzed with mouse antibodies specific for GAPDH (cytoplasmic protein) (AbD serotec, Kidlington, UK) and laminA/C (nuclear protein) (Santa Cruz Biotechnology, Santa Cruz, USA). Immunofluorescence of transfected cells was performed by using as primary antibody either an Mab specific for SFV cytoplasmic nsp2 (kindly provided by W. Bodemer), or an Mab specific for SFV nuclear nsp2 (kindly provided by Dr. L. Kaariainen) (Kujala et al., 1997) .
Analysis of β-gal expression
Transfected cells were lysed as described earlier and the total β-galactosidase activity present in the lysate was measured as described (Liljestrom and Garoff, 1994) , or stained at the indicated times with XGal. The amount of protein produced per cell was obtained by dividing the average amount of β-galactosidase detected per dish by the average number of cells transfected in each dish.
